Medline to distribute Biomerica’s EZ Detect CRC screening test — 3 insights

Medline entered into a three-year agreement to distribute Biomerica’s colorectal disease screening test, EZ Detect.

Advertisement

Here’s what you should know:

1. EZ Detect identifies fecal occult blood, an early sign of CRC.

2. Users throws the EZ Detect pad into the toilet after a bowel movement. The pad changes color to identify if there’s blood in the stool, and the user flushes the pad. It requires no preparation or contact with fecal matter.

3. Medline is the largest privately held medical supply distributor and manufacturer.

More articles on gastroenterology:
USPI makes pair of leadership appointments & more — 5 ASC company key notes
How Andrews Institute Ambulatory Surgery Center cut flash sterilization episodes from 2.4K to 0
Orthopedic Associates of Hartford invested $30M in a new ASC — Drs. Pietro Memmo & Andrew Caputo explain why

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.